Sandrine
Sandrine Agagliate, Paris FR
Patent application number | Description | Published |
---|---|---|
20090196415 | HYBRID METHOD FOR DISTRIBUTING KEYS FOR THE DIFFUSION OF ENCRYPTED DATA - The invention relates to a method for broadcasting data in a system using a BES (A | 08-06-2009 |
20090290484 | METHOD AND SYSTEM MAKING IT POSSIBLE TO MANAGE ERRATIC INTERRUPTIONS IN A TRANSMISSION SYSTEM - Method and system are disclosed for managing erratic interruptions in a transmission system where the messages to be transmitted are composed of data packets and are expressed by means of a polynomial of degree t−1. The senders and the receivers share information making it possible to reference the data packets. In the course of the transmission of a message represented by a polynomial P, at least t points Ai are generated and P(Ai) of the polynomial P is evaluated, with t′ greater than or equal to t. The evaluations P(Ai) are transmitted of the t′ points to the receiver or receivers concerned, with information allowing the receivers to detect the transmission errors. Each receiver verifies that it has received t valid evaluations, that is to say free of transmission errors, uses the information referencing the packets and the t valid evaluations P(Ai) of the polynomial to determine the points Ai, and on the basis of the P(Ai) and of the Ai and determines the polynomial P used and on the basis of said polynomial deduces the message therefrom. | 11-26-2009 |
20090310788 | METHOD FOR MANAGING AND CONTROLLING THE ACCESS KEYS TO SERVICES IN A COMMUNICATION SYSTEM - A method for managing keys making it possible for a user to access one or more given services S in a communication system, in which the user is not able to be continuously connected to this service. A key K(t) is generated, which provides access to the service of day [t] for all the t12-17-2009 | |
Sandrine Alfenore, Castanet -Tolosan FR
Patent application number | Description | Published |
---|---|---|
20120018313 | NOVEL BIOTRACERS AND USES THEREOF FOR CONTROLLING FILTRATION PLANTS - The present invention relates to novel biotracers, to a method for preparing same, and to a method for detecting the biotracers and for monitoring filtration systems. | 01-26-2012 |
Sandrine Allaman, Valence FR
Patent application number | Description | Published |
---|---|---|
20080241404 | Apparatus for Building a Three-Dimensional Article and a Method for Building a Three-Dimensional Article - The invention provides an apparatus for building a three-dimensional article in sequential cross-sectional layers, which apparatus comprises: a powder delivery system comprising one or more reservoirs for delivering a powder and a powder spreading system; a printing system for delivering a liquid; a build chamber comprising a outer wall, an inner wall and a build platform which is movable along the inner wall of the build chamber; and a powder recovery system; wherein the building chamber comprises a space defined by the upper portion between the inner wall and the outer wall of the building chamber and this space is in communication with the powder recovery system and/or the build platform is capable of releasing unused powder (directly) from the build chamber in a downward direction into the powder recovery system. The invention further provides a method building a three-dimensional article wherein use is made of said apparatus. | 10-02-2008 |
Sandrine Bailloux, Noyers-Bocage FR
Patent application number | Description | Published |
---|---|---|
20090327895 | Streaming Distribution of Multimedia Digital Documents Via a Telecommnnication Network - A system for supplying digital multimedia documents via a telecommunications network. The system includes document server means ( | 12-31-2009 |
Sandrine Batifoulier, Pourrieres FR
Patent application number | Description | Published |
---|---|---|
20090210644 | Access Rights on a Memory Map - A microcontroller system, such as a system-on-a-chip integrated circuit, including a processor (e.g., a Von Neumann processor), memory, and a memory protection unit (MPU), where the MPU provides execute-only access rights for one or more protected areas of the memory. The MPU can allow instructions fetched from within a protected area to access data in the protected area while preventing instructions fetched from outside the protected area from accessing data in the protected area. | 08-20-2009 |
20110138141 | EXECUTE ONLY ACCESS RIGHTS ON A VON NEUMAN ARCHITECTURES - A microcontroller system, such as a system-on-a-chip integrated circuit, including a processor (e.g., a Von Neumann processor), memory, and a memory protection unit (MPU), where the MPU provides execute-only access rights for one or more protected areas of the memory. The MPU can allow instructions fetched from within a protected area to access data in the protected area while preventing instructions fetched from outside the protected area from accessing data in the protected area. | 06-09-2011 |
Sandrine Biscarrat, Gif Sur Yvette FR
Patent application number | Description | Published |
---|---|---|
20100056553 | Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives - The invention relates to 6-substituted isoquinoline and isoquinolinone derivatives of the formula (I) | 03-04-2010 |
20100144757 | DERIVATIVES OF 7-ALKYNYL-1,8-NAPHTHYRIDONES, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS - The disclosure relates to 7-alkynyl-1,8-naphthyridones of formula (I): | 06-10-2010 |
20120277220 | 5 OXO-5,8-DIHYDROPYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS CAMKII KINASE INHIBITORS FOR TREATING CARDIOVASCULAR DISEASES - The present invention relates to 5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives, to their preparation and to their therapeutic use. | 11-01-2012 |
Sandrine Biscarrat, Paris FR
Patent application number | Description | Published |
---|---|---|
20110190340 | BI- AND POLYCYCLIC SUBSTITUTED ISOQUINOLINE AND ISOQUINOLINONE DERIVATIVES - The invention relates to bi- and polycyclic substituted isoquinoline and isoquinolinones of the formula (I) wherein R | 08-04-2011 |
Sandrine Bouley, Betterans FR
Patent application number | Description | Published |
---|---|---|
20120064598 | Mutation of the parkin gene, compositions, methods and uses - The invention concerns nucleic acids coding for mutated or truncated forms of the human parkin gene, or forms comprising multiplication of exons, and the corresponding proteins and antibodies. The invention also concerns methods and kits for identifying mutations of the parkin gene, and for studying compounds for therapeutic purposes. | 03-15-2012 |
Sandrine Boyault, Rillieux La Pape FR
Patent application number | Description | Published |
---|---|---|
20100015605 | HEPATOCELLULAR CARCINOMA CLASSIFICATION AND PROGNOSIS - Methodology for the in vitro classification and/or prognosis of hepatocellular carcinoma (HCC) from a HCC sample is based on the determination of the expression profile of particular gene combinations. | 01-21-2010 |
Sandrine Briate, St-Anaclet CA
Patent application number | Description | Published |
---|---|---|
20120077747 | FISH-DERIVED PROTEIN LYSATE, AND USES THEREOF AS IMMUNOMODULATORY AND/OR ANTI-INFLAMMATORY AGENT - A peptide-comprising extract derived from fish is described. Also disclosed is a process for obtaining a peptide-comprising extract derived from fish, as well as an extract obtained by this process. Compositions comprising such an extract are also described. Uses of such extracts/compositions, as well as corresponding methods of treatment, for example to prevent and/or treat an inflammatory and/or immune disease-related discomfort in a subject, are also described. | 03-29-2012 |
Sandrine Briatte, St-Anaclet-De-Lessard CA
Patent application number | Description | Published |
---|---|---|
20110150795 | COSMETIC COMPOSITIONS COMPRISING EXOPOLYSACCHARIDES DERIVED FROM MICROBIAL MATS, AND USE THEREOF - Disclosed herein is a skin care composition comprising at least one exopolysaccharide (EPS) originating from a microbial mat, wherein the EPS is in a concentration of about 0.001% w/w to about 1.5 w/w of the composition. Preferably, the EPS is derived from microorganism isolated from microbial mats found in French Polynesia. The composition is useful in reducing and preventing signs of skin aging and environmental damage by altering skin cell metabolism and improving hydration. | 06-23-2011 |
Sandrine Busseret, Lyon FR
Patent application number | Description | Published |
---|---|---|
20100136539 | EZRIN ASSAY METHOD FOR THE IN VITRO DIAGNOSIS OF COLORECTAL CANCER - A method for the in vitro diagnosis of colorectal cancer by determining the presence of the Ezrin tumor marker in a biological sample taken from a patient suspected of having colorectal cancer using at least one anti-Ezrin monoclonal antibody directed against an Ezrin epitope chosen from the epitopes of sequence SEQ ID No.1, SEQ ID No.2, SEQ ID No.3, SEQ ID No.4+SEQ ID No.5, SEQ ID No.6+SEQ ID No.7 and SEQ ID No.8. Said method can be used for early diagnosis, screening, therapeutic follow-up and prognosis, and also for relapse diagnosis in relation to colorectal cancer. | 06-03-2010 |
20110104701 | PROTEIN DISULFIDE ISOMERASE ASSAY METHOD FOR THE IN VITRO DIAGNOSIS OF COLORECTAL CANCER - A method for the in vitro diagnosis of colorectal cancer by determining the presence of the protein disulfide isomerase tumor marker in a biological sample taken from a patient suspected of having colorectal cancer using at least one anti-PDI monoclonal antibody directed against a PDI epitope chosen from the epitopes of sequence SEQ ID NO: 1, SEQ ID NO: 2 with an aromatic amino acid having a three-dimensional structure similar to that of PDI, and SEQ ID NO: 3. | 05-05-2011 |
20120129200 | PRODEFENSIN-A6 ASSAY METHOD FOR THE IN VITRO DIAGNOSIS OF COLORECTAL CANCER - The present invention relates to a method for the in vitro diagnosis of colorectal cancer by determining the presence of the Prodefensin-A6 tumour marker in a biological sample taken from a patient suspected of having colorectal cancer, it being possible for said method to be used both in early diagnosis, screening, therapeutic follow-up and prognosis, and in relapse diagnosis in relation to colorectal cancer. | 05-24-2012 |
20130102758 | EZRIN ASSAY METHOD FOR THE IN VITRO DIAGNOSIS OF COLORECTAL CANCER - A method for the in vitro diagnosis of colorectal cancer by determining the presence of the Ezrin tumor marker in a biological sample taken from a patient suspected of having colorectal cancer using at least one anti-Ezrin monoclonal antibody directed against an Ezrin epitope chosen from the epitopes of sequence SEQ ID No.1, SEQ ID No.2, SEQ ID No.3, SEQ ID No.4+SEQ ID No.5, SEQ ID No.6+SEQ ID No.7 and SEQ ID No.8. Said method can be used for early diagnosis, screening, therapeutic follow-up and prognosis, and also for relapse diagnosis in relation to colorectal cancer. | 04-25-2013 |
20140017710 | PROCESS AND KIT FOR IN VITRO DIAGNOSIS OF A PROSTATE CANCER - The object of the present invention is a process for in vitro diagnosis of a prostate cancer, according to which a urine sample to be analysed is contacted with two antibodies, a capture antibody and a detection antibody, one of the two antibodies being directed against the first repeat domain of native human Annexin A3 identified as SEQ ID NO: 1, and the other of the two antibodies being directed against the fourth repeat domain of native human Annexin A3, identified as SEQ ID NO: 2, as well as a kit for implementing the process. | 01-16-2014 |
20140039154 | PROTEIN DISULFIDE ISOMERASE ASSAY METHOD FOR THE IN VITRO DIAGNOSIS OF COLORECTAL CANCER - A method for the in vitro diagnosis of colorectal cancer that comprises determining the presence of the protein disulfide isomerase tumor marker in a biological sample taken from a patient suspected of having colorectal cancer using at least one anti-PDI monoclonal antibody directed against a PDI epitope chosen from the epitopes of sequence SEQ ID No.1, SEQ ID No.2, with an aromatic amino acid which is close in the three-dimensional structure of PDI and SEQ ID No.3. | 02-06-2014 |
20140051067 | PROCESS FOR THE DETECTION AND EARLY SEROTYPING OF THE DENGUE VIRUS - Disclosed is a process for in vitro detection of an infection by a dengue virus in an individual, including the following steps: contacting a blood sample from the individual with a ligand specific to the NS1 protein of said dengue virus, to capture NS1 protein if it is present in the blood sample, said ligand being immobilized on a solid support; detecting the presence of NS1 protein via a mass spectrometry reading; and if NS1 protein is detected, concluding that the individual has been infected by dengue virus. | 02-20-2014 |
Sandrine Chalaye, Royas FR
Patent application number | Description | Published |
---|---|---|
20090188638 | PROCESS FOR MANUFACTURING A MATERIAL IN SHEET FORM, COMPRISING AT LEAST ONE FIBROUS LAYER AND SECURITY AND/OR DECORATIVE ELEMENTS - A process for manufacturing a material in sheet form, comprising at least one fibrous layer and a plurality of security and/or decorative elements, the process comprising at least one of the following steps: the security and/or decorative elements are sprayed onto one face of the fibrous layer, which is running along a predetermined direction, especially when the fibrous layer is still wet, so as to form at least one continuous pattern having at least one edge, approximately along the run direction, not entirely parallel to the run direction, and a pattern comprising a succession of separate zones, and security and/or decorative elements of at least two different types and/or having a variable concentration are sprayed onto one face of the fibrous layer, especially when it is still wet. | 07-30-2009 |
Sandrine Chodorowski-Kimmes, Forterelle FR
Patent application number | Description | Published |
---|---|---|
20100278764 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS - Disclosed herein is a cosmetic and/or pharmaceutical composition comprising, in a physiologically acceptable medium, at least one (co)polymer comprising a polymer backbone and at least one junction group linked to the polymer backbone and capable of establishing H bonds with at least one partner junction group, each pairing of a junction group involving at least 3H bonds, wherein the at least one (co)polymer comprises at least one ionizable group. Also disclosed herein is a cosmetic treatment process comprising applying the composition to keratin materials. | 11-04-2010 |
20120027698 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS - Disclosed herein is a cosmetic and/or pharmaceutical composition comprising, in a physiologically acceptable medium, at least one (co)polymer comprising a polymer backbone and at least one junction group linked to the polymer backbone and capable of establishing H bonds with at least one partner junction group, each pairing of a junction group involving at least 3H bonds, wherein the at least one (co)polymer comprises at least one ionizable group. Also disclosed herein is a cosmetic treatment process comprising applying the composition to keratin materials. | 02-02-2012 |
Sandrine Chodorowski-Kimmes, Senlis FR
Patent application number | Description | Published |
---|---|---|
20100028277 | COMPOSITION CONTAINING A COMPOUND CAPABLE OF ESTABLISHING HYDROGEN BONDS, AND COSMETIC TREATMENT PROCESS - Composition containing, in a cosmetically or dermatologically acceptable medium, a compound that may be obtained by reaction between: | 02-04-2010 |
20100154134 | COMPOSITION FOR DYEING KERATIN FIBERS, COMPRISING AT LEAST ONE POLYALKENE-BASED SUPRAMOLECULAR POLYMER, AT LEAST ONE PIGMENT AND AT LEAST ONE VOLATILE SOLVENT - The present disclosure relates to a composition for dyeing keratin fibers, comprising at least one polyalkene-based supramolecular polymer, at least one pigment and at least one volatile solvent, wherein the weight ratio of the at least one supramolecular polymer to the at least one pigment has a value greater than 0.25, and also a process for dyeing keratin fibers using this composition. The present disclosure may make it possible to obtain, on the keratin fibers, colored coatings for keeping the hairs individualized while at the same time preserving the physical qualities of the fiber. | 06-24-2010 |
20100158832 | COSMETIC COMPOSITION COMPRISING A SUPRAMOLECULAR POLYMER AND METHOD FOR MAKING UP THE SKIN AND/OR LIPS EMPLOYING A COMPOSITION COMPRISNG A SUPRAMOLECULAR POLYMER - The present disclosure relates to a method for making up the skin and/or lips, wherein a cosmetic makeup composition comprising, in a cosmetically acceptable medium, at least one polyalkene-based supramolecular polymer is applied. The disclosure also relates to a cosmetic composition for making up the skin and/or lips, comprising, in a cosmetically acceptable medium, at least one polyalkene-based supramolecular polymer and at least one coloring material. | 06-24-2010 |
20100239509 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS - The present patent application relates to a cosmetic or dermatological composition comprising, in a cosmetically or dermatologically acceptable medium, a polymer comprising: | 09-23-2010 |
20100242188 | COMPOSITION FOR COLOURING KERATINOUS MATERIAL USING A SUPRA-MOLECULAR COLOURING SYSTEM - The present invention relates to a composition for colouring keratinous materials. The composition contains in an appropriate medium at least one supra-molecular colouring system of the type (COLORANT) | 09-30-2010 |
20120315230 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD AND COMPOUND - The invention relates to a cosmetic composition comprising, in a cosmetically acceptable medium, a compound that can be obtained by reaction between an OH-functionalized or COOH-functionalized wax and a junction group capable of establishing hydrogen bonds with one or more partner junction groups, said junction group comprising at least one unit of formula (I) or (II): | 12-13-2012 |
20130017164 | COSMETIC DERMATOLOGICAL COMPOSITION, COSMETIC TREATMENT METHOD, AND HYALURONIC ACID DERIVATIVE - The invention relates to a cosmetic or dermatological composition comprising a hyaluronic acid derivative which comprises ureidopyrimidone units, to the said derivatives and to a cosmetic treatment method using them. | 01-17-2013 |
20130136705 | COSMETIC COMPOSITION COMPRISING AN OIL AND A POLYMER BOTH BEARING A HYDROGEN-BOND-GENERATING JOINING GROUP, AND COSMETIC TREATMENT PROCESS - The present invention relates to a cosmetic composition comprising: | 05-30-2013 |
20130195778 | COSMETIC COMPOSITION COMPRISING A POLYSILOXANE AND A POLYMER BOTH BEARING A HYDROGEN-BOND-GENERATING JOINING GROUP, AND COSMETIC TREATMENT PROCESS - The present invention relates to a cosmetic composition comprising: | 08-01-2013 |
Sandrine Cigarini, Saint Genis Les Ollieres FR
Patent application number | Description | Published |
---|---|---|
20090110699 | Antigen-Adjuvant Compositions and Methods - Vitreous compositions of an antigen and adjuvant, and methods for making the compositions are disclosed. Also disclosed are pharmaceutically acceptable formulations of the vitreous compositions, reconstituted liquid formulations of the vitreous compositions, vaccine compositions, and kits containing the vitreous compositions. Also disclosed are devices for administering the vitreous compositions to mammals and methods for eliciting an immune response in mammals by administering the compositions. | 04-30-2009 |
20110081380 | Stabilizing Excipient for Inactivated Whole Virus Vaccine - The invention relates to a vaccine composition comprising: | 04-07-2011 |
20140037684 | STABILIZING EXCIPIENT FOR INACTIVATED WHOLE VIRUS VACCINE - The invention relates to a vaccine composition comprising: | 02-06-2014 |
Sandrine Crisafulli, Geneva CH
Patent application number | Description | Published |
---|---|---|
20090065043 | METHOD OF COUPLING PHOTOVOLTAIC CELLS AND FILM FOR IMPLEMENTING IT - Method for electrically connecting photovoltaic cells ( | 03-12-2009 |
Sandrine Dallalibera, Pogny FR
Patent application number | Description | Published |
---|---|---|
20100209717 | Water Re-Dissolvable Adhesive - Aqueous adhesive containing, based on solid contents, −20 to 80% by weight of an (meth)acrylic copolymer (A) as dispersion in water, −10 to 50% by weight of a resin (B), −5 to 30% by weight of a reaction product (C) of | 08-19-2010 |
Sandrine Decarre, Rueil-Malmaison FR
Patent application number | Description | Published |
---|---|---|
20080262808 | METHOD FOR DIMENSIONING INDUSTRIAL INSTALLATIONS WHERE A TWO-PHASE GAS-LIQUID MIXTURE FLOWS IN AN INTERMITTENT REGIME - Method for dimensioning industrial installations where a two-phase gas-liquid mixture flows in an intermittent regime. | 10-23-2008 |
Sandrine Deilhes, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20090020646 | ASSEMBLY OF PANELS OF AN AIRPLANE FUSELAGE - An aircraft fuselage including at least two sections kept assembled at a circumferential join, each section having at least one panel. The circumferential join includes at least one inner ring, situated on one face, called the inner face, of the fuselage. The inner ring has a width l | 01-22-2009 |
Sandrine Delabroye, Hantay FR
Patent application number | Description | Published |
---|---|---|
20090165181 | Heuchera plant named 'Pinot Noir' - A new cultivar of | 06-25-2009 |
20090165182 | Heuchera plant named "Tiramisu" - A new cultivar of | 06-25-2009 |
Sandrine Delbary-Gossart, Mauzac FR
Patent application number | Description | Published |
---|---|---|
20110144116 | DERIVATIVES OF (BRIDGED PIPERAZINYL)-1-ALKANONE AND USE THEREOF AS p75 INHIBITORS - The present invention relates to derivatives of ((phenyl)-3,6-dihydropyridin-1-yl)(bridged piperazinyl)-1-alkanone derivatives and ((phenyl)-2,5-dihydropyrrol-1-yl) (bridged piperazinyl)-1-alkanone corresponding to Formula (I): | 06-16-2011 |
20110144122 | DERIVATIVES OF 2-OXOALKYL-1-PIPERAZIN-2-ONE, PREPARATION METHOD THEREOF AND THERAPEUTIC USE OF SAME - The present invention relates to derivatives of 4-{2-[phenyl-3,6-dihydropyridin-1-yl]-2-oxoalkyl}-1-piperazin-2-one and 4-{2-[phenyl-2,5-dihydropyrrol-1-yl]-2-oxoalkyl}-1-piperazin-2-one having general formula (I): | 06-16-2011 |
20120232280 | DERIVATIVES OF (BRIDGED PIPERAZINYL)-1-ALKANONE AND USE THEREOF AS p75 INHIBITORS - The present invention relates to derivatives of ((phenyl)-3,6-dihydropyridin-1-yl)(bridged piperazinyl)-1-alkanone derivatives and ((phenyl)-2,5-dihydropyrrol-1-yl) (bridged piperazinyl)-1-alkanone corresponding to Formula (I): | 09-13-2012 |
20120245149 | NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS - The disclosure relates to (heterocycle-fused piperidine)-(piperazinyl)-1-alkanone derivatives and (heterocycle-fused pyrrolidine)-(piperazinyI)-1-alkanone derivatives of formula (I): | 09-27-2012 |
20120245150 | NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS - The disclosure relates to (heterocycle-tetrahydropyridine)(piperazinyl)-1-alkanone and (heterocycle-dihydropyrrolidine)(piperazinyl)-1-alkanone derivatives of formula (I): | 09-27-2012 |
20120289518 | DERIVATIVES OF 2-OXOALKYL-1-PIPERAZIN-2-ONE, PREPARATION METHOD THEREOF AND THERAPEUTIC USE OF SAME - The present invention relates to derivatives of 4-{2-[phenyl-3,6-dihydropyridin-1-yl]-2-oxoalkyl}-1-piperazin-2-one and 4-{2-[phenyl-2,5-dihydropyrrol-1-yl]-2-oxoalkyl}-1-piperazin-2-one having general formula (I): | 11-15-2012 |
20130303520 | NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS - The disclosure relates to (heterocycle-tetrahydropyridine)(piperazinyl)-1-alkanone and (heterocycle-dihydropyrrolidine)(piperazinyl)-1-alkanone derivatives of formula (I): | 11-14-2013 |
20140038946 | NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS - The disclosure relates to (heterocycle-fused piperidine)-(piperazinyl)-1-alkanone derivatives and (heterocycle-fused pyrrolidine)-(piperazinyl)-1-alkanone derivatives of formula (I): | 02-06-2014 |
Sandrine Deltour, Vincennes FR
Patent application number | Description | Published |
---|---|---|
20090326360 | METHOD FOR ESTIMATING THE GROWTH POTENTIAL OF CEREBRAL INFARCTS - The invention relates to a method for automatic estimation of the growth potential of cerebral infarcts, particularly in the acute phase, that is to say in the six hours following survival of the stroke. The method includes sequences of diffusion MRI images are obtained, the apparent diffusion coefficient (ADC) is calculated at a multiplicity of points or voxels of the cortical parenchyma, and locating and delimiting the initial infarct and modelling the development of the infarct based on a growth model. | 12-31-2009 |
Sandrine Duluard, Charenton Le Pont FR
Patent application number | Description | Published |
---|---|---|
20110070361 | NON-ELECTROLYTIC DEPOSITION METHOD - The invention relates to a method for the non-electrolytic deposition of a compound, preferably an electrochromic compound, comprising the following successive steps: (a) an electroconductive layer is deposited on a non-conductive solid substrate; (b) a reducing agent or an oxidizing agent (=redox agent) is deposited on an area of said electroconductive layer, said area covering only a portion of the surface of said electroconductive layer; and (c) a solution of a precursor of the compound to be deposited is brought into contact both with the redox agent and with at least a portion of the area of said electroconductive layer not covered by the redox agent, said precursor being chosen from those having an oxidation-reduction potential higher or lower than the redox agent and forming, after an oxidation-reduction reaction, a compound insoluble in the solution of the precursor of the compound to be deposited. | 03-24-2011 |
20110211245 | TRANSPARENT ELECTROACTIVE SYSTEM - The invention relates to a transparent electroactive system that includes two electrodes ( | 09-01-2011 |
20120120477 | TRANSPARENT ELECTROCHROMIC SYSTEM - A transparent electrochromic system includes a cellular structure, two power supply electrodes together supported on a single wall, and at least one additional electrode. The additional electrode can be used as a reference electrode or as a polarization electrode. The additional electrode can also form a condenser with a fourth electrode that is added to the system, in order to control a migration of certain electroactive substances responsible for coloring and decoloring the system. The operation of the system can thus be improved. | 05-17-2012 |
20120176661 | TRANSPARENT ELECTROCHROMIC SYSTEM WITH A PLURALITY OF PAIRS OF SUPPLY ELECTRODES - The invention relates to a transparent electrochromic system ( | 07-12-2012 |
20120307340 | TRANSPARENT ELECTROCHROMIC SYSTEMS WITH A PLURALITY OF POLARISATION ELECTRODES - The invention relates to transparent electrochromic systems which each include one pair of supply electrodes and at least one pair of polarisation electrodes. The polarisation electrodes prevent a reaction of mutual neutralisation of the electroactive substances of the systems from causing unnecessary consumption of electric current. Said electrodes also prevent a neutralisation reaction from limiting a lower value of light transmission of the systems. For this purpose, the polarisation electrodes produce an electric field inside the systems, which attracts the electroactive substances that have already reacted with the supply electrodes to different areas. | 12-06-2012 |
20130078458 | METHOD FOR THE LOW-TEMPERATURE PREPARATION OF ELECTRICALLY CONDUCTIVE MESOSTRUCTURED COATINGS - The present invention relates to a method for manufacturing mesostructural coatings comprising electrically conductive structures formed of metal nanoparticles. Said method includes the steps that involve: a) depositing on a substrate, a first layer consisting of a silica material, mesostructured by a structuring agent, and a photocatalytic material: b) depositing on the first layer, a second layer of a mesostructural silica material, said second layer being free of photocatalytic material: c) consolidating the first and second layers at at temperature between 50° C. and 250° C.; and d) placing the consolidating coating in contact with a solution that contains and irradiatting coating with a radiation that enables the photocatalytic material to be activated. Said method is characterized in that it includes no heat treatment at a temperature greater than 250° C. | 03-28-2013 |
20130142945 | PROCESS FOR MANUFACTURING AN ELECTROCHROMIC ARTICLE - The present invention relates to a process for manufacturing an electrochromic article, comprising the following successive steps: (a) deposition of a layer of an electrochromic compound on the surface of a transparent or translucent electroconductive substrate; (b) deposition of a redox agent, which is a reducing agent or an oxidizing agent for the electrochromic compound, on the layer of electrochromic compound at a multitude of discrete points or areas thereon; (c) bringing the layer of electrochromic compound, deposited in step (a), and the redox agent, deposited in step (b), into contact with a liquid electrolyte for a time long enough to allow the electrochromic compound to be reduced or oxidized by the redox agent; and (d) elimination of the electrolyte by rinsing and/or drying, the layer of electrochromic compound being a porous layer of open porosity and/or an electrically conductive layer. | 06-06-2013 |
Sandrine Gandelot, Montrouge FR
Patent application number | Description | Published |
---|---|---|
20090097971 | TURBINE STATOR FOR AIRCRAFT TURBINE ENGINE INCLUDING A VIBRATION DAMPING DEVICE - This invention relates to a turbine stator ( | 04-16-2009 |
20100028147 | DIFFUSER/GUIDE VANE ASSEMBLY FOR A TURBOMACHINE - Diffuser/guide vane assembly ( | 02-04-2010 |
20120308374 | DIFFUSER-GUIDE VANE CONNECTION FOR A CENTRIFUGAL COMPRESSOR - An assembly including a diffuser and an airflow rectifier at an outlet of a centrifugal compressor of a turbine engine, the diffuser being substantially in a shape of a radially positioned double annular disc, and the rectifier being a double toroidal part, arranged as an extension of the double disc of the diffuser and curved such as to divert the airflow in the downstream direction of the engine. The rectifier is attached to the diffuser by a connection positioned immediately adjacent to the contact surface of the two parts and is removable using a standard tool, excluding any other supporting mechanism. | 12-06-2012 |
Sandrine Gremlich, La Tour-De-Treme CH
Patent application number | Description | Published |
---|---|---|
20100111933 | ACID SOLUBLE PROTEINS FROM MICELLAR CASEIN - The present invention relates to a milk fraction obtainable by acidification of micellar casein and separation from precipitated casein named acid soluble protein from micellar casein. It was found that the milk fraction and especially certain sub-fractions thereof are bioactive and promote GLP-1 release in vitro. Based on these results, acid soluble protein from micellar casein may be useful in the treatment and the prevention of diabetes type II, obesity and may further be added to formulas directed at other purposes addressing the gastro-intestinal tract. | 05-06-2010 |
20100297253 | TREATMENT OF DIABETES WITH MILK PROTEIN HYDROLYSATE - A milk protein hydrolysate which is preferably caseinoglycomacropeptide and/or a whey protein in a bioavailable form is used for the manufacture of a composition for the treatment or prevention of diabetes or syndrome X. The invention also relates to a method of treatment or prevention of diabetes or syndrome X utilizing such compositions, a method for assessing proglucagon gene expression and GLP-1 release by a cell line derived from an adenocarcinoma of human caecum. | 11-25-2010 |
Sandrine Hilairet, Saint Andre De Sangonis FR
Patent application number | Description | Published |
---|---|---|
20100222319 | NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF - The disclosure relates to compounds of formula (I): | 09-02-2010 |
Sandrine Hilairet, Paris FR
Patent application number | Description | Published |
---|---|---|
20120094986 | ANTICANCER DERIVIATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF - The invention relates to nicotinamide derivatives which can be used as anticancer drugs. | 04-19-2012 |
Sandrine Houee, Amilly FR
Patent application number | Description | Published |
---|---|---|
20110303318 | Pipe for the Air Intake Circuit of a Motor Vehicle Engine, and Circuit Incorporating the Same - The present invention relates to a pipe usable for an air intake circuit of a motor vehicle engine, and to this air intake circuit in particular for the intake of air at the outlet of a turbocompressor that comprises at least one such pipe. | 12-15-2011 |
Sandrine Ithurria, Paris FR
Patent application number | Description | Published |
---|---|---|
20090324968 | COMPOSITION FOR HYDROPHOBIC TREATMENT AND GLAZING - Hydrophobic treatment composition comprising one or more compounds, as a mixture, corresponding to the formula | 12-31-2009 |
20110248222 | PROCESS FOR MANUFACTURING COLLOIDAL MATERIALS, COLLOIDAL MATERIALS AND THEIR USES - The present invention relates to a process for manufacturing a colloidal material, to colloidal materials obtainable by this process and to uses of said colloidal material for the manufacture of optic devices. The colloidal material obtainable by the process of the present invention is of formula A | 10-13-2011 |
20130220405 | PROCESS FOR MANUFACTURING COLLOIDAL NANOSHEETS BY LATERAL GROWTH OF NANOCRYSTALS - A process for manufacturing colloidal nanosheet, by lateral growth, on an initial colloidal nanocrystal, of a crystalline semiconductor material represented by the formula M | 08-29-2013 |
Sandrine Jourda, Colombes FR
Patent application number | Description | Published |
---|---|---|
20120098727 | PARABOLIC ANTENNA POSITIONER - The parabolic antenna positioner includes a base, a support cradle mounted so it can rotate relative to the base along a first axis of rotation, a mobile assembly including a parabolic antenna, supported by the support cradle, and mounted so it can rotate relative to the support cradle along a second axis of rotation, orthogonal to the first axis of rotation. The second axis of rotation is separated from the axis of rotation of the support cradle by a non-null distance measured in the plane of rotation of the cradle. | 04-26-2012 |
Sandrine Lamarque-Forget, Magny Les Hameaux FR
Patent application number | Description | Published |
---|---|---|
20120160393 | METHOD FOR MAKING BISTABLE NEMATIC LIQUID-CRYSTAL DEVICES - The object of the invention is a method for making devices with bistable nematic liquid crystals, having a nematic liquid crystal layer placed between two plates, each plate including a strip, an electrode and an alignment layer for nematic liquid crystal, at least one of said alignment layers having low zenithal anchoring for said liquid crystal, small pre-tilt and medium or strong azimuthal anchoring, wherein said at least one of the alignment layers is prepared by depositing a solution comprising a polymer, said polymer is a copolymer or a terpolymer derived from vinyl chloride and vinyl ethers, said solution further comprising an additive, selected from the group formed by aromatic polyimides, precursors of the aromatic polyamic acid type or a mixture of these compounds. | 06-28-2012 |
Sandrine Lataste, Paris FR
Patent application number | Description | Published |
---|---|---|
20100223282 | Database and a Method for Obtaining the Address of a Quality of Service and Charging Control Entity In an Ims Network using Such a Database - A database ( | 09-02-2010 |
Sandrine Lebas, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20090188493 | NASAL DEVICES - Described herein are adhesive nasal devices. In particular, the adhesive nasal respiratory devices described herein are configured to be worn in communication with a subject's nasal cavity and may include a rim body having a passageway therethrough, an airflow resistor in communication with the passageway of the rim body, and a flexible, adhesive holdfast layer extending outward from the periphery of the rim body. The rim body region may be formed from multiple parts (e.g., a first and a second rim body region), and the airflow resistor may be secured between the parts forming the rim body. Methods of manufacturing and assembling these adhesive nasal devices are also described. | 07-30-2009 |
20110240038 | NASAL DEVICES - Described herein are adhesive nasal devices. In particular, the adhesive nasal respiratory devices described herein are configured to be worn in communication with a subject's nasal cavity and may include a rim body having a passageway therethrough, an airflow resistor in communication with the passageway of the rim body, and a flexible, adhesive holdfast layer extending outward from the periphery of the rim body. The rim body region may be formed from multiple parts (e.g., a first and a second rim body region), and the airflow resistor may be secured between the parts forming the rim body. Methods of manufacturing and assembling these adhesive nasal devices are also described. | 10-06-2011 |
20140124597 | Volatile Material Dispenser Having a Faceplate - A volatile material dispenser includes a housing and a dispensing mechanism disposed within the housing for emitting a volatile material. A faceplate is attached to the housing and provides an aesthetically pleasing look to the volatile material dispenser. | 05-08-2014 |
Sandrine Lentsch Graf, Sainte Foy Les Lyon FR
Patent application number | Description | Published |
---|---|---|
20120091026 | Method of Storing a Vaccine Containing an Aluminum Adjuvant - The invention relates to a method for loading and storing a vaccine composition, containing the antigen adsorbed on the aluminum adjuvant which (a) comprises (i) loading the composition into a container; and (ii) closing the container with a device in particular acting as a stopper, the surface of the device getting into contact with the composition being coated with a fluoropolymer such as Teflon™; and/or (b) loading the composition into a container wherein the inner surface of which is coated with polymerized silicone. The use of fluoropolymer or polymerized silicone optimizes the adsorbed antigen stability upon storage. In a particular embodiment, the antigen is the hepatitis B surface antigen and the aluminum adjuvant is aluminum oxy hydroxide. | 04-19-2012 |
20140370049 | METHOD FOR FORMULATING A VACCINE CONTAINING AT LEAST TWO ANTIGENS CAPABLE OF ADSORBING ONTO ALUMINIUM OXYHYDROXIDE - The subject matter of the invention is a method for preparing a vaccine composition comprising at least aluminium oxyhydroxide (AlOOH), and at least the hepatitis B surface antigen and the | 12-18-2014 |
Sandrine Lhostis, Theys FR
Patent application number | Description | Published |
---|---|---|
20100059834 | INTEGRATED ELECTRONIC CIRCUIT INCLUDING A THIN FILM PORTION BASED ON HAFNIUM OXIDE - An integrated electronic circuit has a thin layer portion based on hafnium oxide. This portion additionally contains magnesium atoms, so that the portion is in the form of a hafnium-and-magnesium mixed oxide. Such a portion has a high dielectric constant and a very low leakage current. It is particularly suitable for forming a part of a gate insulation layer of a MOS transistor or a part of a MIM capacitor dielectric. | 03-11-2010 |
20140070158 | PHASE-CHANGE MEMORY CELL - A memory cell including a via made of a phase-change material arranged between a lower electrode and an upper electrode, wherein the via includes a central region laterally surrounded with a peripheral region, the crystallization and melting temperatures of the central region being respectively lower than those of the peripheral region. | 03-13-2014 |
20140070163 | PHASE-CHANGE MEMORY CELL - A memory cell including a via made of a phase-change material arranged between a lower electrode and an upper electrode, wherein the via includes a first region adjacent to a second region itself adjacent to at least one third region, the first, second, and third regions each extending from the upper electrode to the lower electrode, the crystallization temperature of the second region ranging between that of the first region and that of the third region, and the melting temperatures of the first, second, and third regions being substantially identical. | 03-13-2014 |
20140210071 | INTEGRATED STRUCTURE WITH IMPROVED HEAT DISSIPATION - An integrated structure includes a support supporting at least one chip and a heat dissipating housing, attached to the chip. The housing is thermally conductive and has a thermal expansion compatible with the chip. The housing may further including closed cavities filled with a phase change material. | 07-31-2014 |
20140374574 | FORMING OF A NANOSTRUCTURED SPECTRAL FILTER - A spectral filter includes an assembly of filtering cells. Each cell has a same nanostructured pattern and a preferential direction of the pattern. This preferential direction is, for each cell, oriented approximately radially with respect to a single point of the spectral filter. Alternatively, this preferential direction is, for each cell, oriented approximately ortho-radially with respect to the single point of the spectral filter. The single point may be a center point. Alternatively, the single point may correspond to an optical axis of a lens element associated with the spectral filter. | 12-25-2014 |
20150075749 | INTEGRATED CIRCUIT CHIP COOLING DEVICE - An integrated circuit chip cooling device includes a network of micropipes. A first pipe portion and a second pipe portion of the network are connected by at least one valve. The valve is formed of a bilayer strip. In response to change in temperature, the shape of the bilayer strip changes to move the valve from a substantially closed position to an open position. In one configuration, the change is irreversible. In another configuration, the change is reversible in response to an opposite change in temperature. | 03-19-2015 |
20150083900 | PROXIMITY SENSOR INCLUDING REFERENCE DETECTOR FOR STRAY RADIATION DETECTION - A proximity sensor includes a radiation source configured to emit a primary radiation beam and a primary detector configured to pick up a reflected primary radiation beam. The radiation source is further configured to emit stray radiation. The sensor further includes a reference detector arranged to receive the stray radiation. The stray radiation may, for example, be emitted from either a side of the radiation source or a bottom of the radiation source. | 03-26-2015 |
Sandrine Mabire, Vetraz-Monthoux FR
Sandrine Magnard, La Valla En Gier FR
Patent application number | Description | Published |
---|---|---|
20100056482 | Calixarene Derivatives as Anticancer Agent - This invention relates to compounds having the following formula (I): | 03-04-2010 |
Sandrine Marlin-Duvernois, Colombes FR
Patent application number | Description | Published |
---|---|---|
20090104600 | Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection - A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide. | 04-23-2009 |
20120322059 | MUTATION WITHIN THE CONNEXIN 26 GENE RESPONSIBLE FOR PRELINGUAL NON-SYNDROMIC DEAFNESS AND METHOD OF DETECTION - A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide. | 12-20-2012 |
20140113285 | MUTATION WITHIN THE CONNEXIN 26 GENE RESPONSIBLE FOR PRELINGUAL NON-SYNDROMIC DEAFNESS AND METHOD OF DETECTION - A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide. | 04-24-2014 |
Sandrine Millasseau, Surrey GB
Patent application number | Description | Published |
---|---|---|
20080255463 | Method of Obtaining an Estimation of a Person's Aortic Blood Pressure - A method of obtaining an estimation of a person's aortic systolic blood pressure, which method comprises non-invasively measuring the person's brachial systolic blood pressure, non-invasively measuring the person's brachial diastolic blood pressure, obtaining the person's radial augmentation index by measuring the person's radial pulse waveform, and obtaining the estimation of the person's aortic systolic blood pressure from the following equation: aSBP=α+β·rA1x+γ·bSBP+δ·bDBP where the coefficients α, β, γ and δ are constants with approximate values of α=−24.2, β=0.28, γ=0.83, δ=0.17. | 10-16-2008 |
Sandrine Millot, Saint Genis Laval FR
Patent application number | Description | Published |
---|---|---|
20090215939 | Method for Hydrophobising and Improving the Beading Effect of Construction Materials - The invention relates to the use of waterproofing liquid silicon compositions for impregnating porous construction materials, for example mineral or (ligno)cellulose materials. | 08-27-2009 |
Sandrine Minebois, Haisnes FR
Patent application number | Description | Published |
---|---|---|
20100200518 | FILTER ELEMENT, SECURING RING AND METHOD FOR FILTERING - The invention relates to a filter element for a press filter comprising first and second filtering means, each having at least one opening for the passage of a slurry to be filtered, and first and second connecting means for connecting the openings of the first and second filtering means. Each of the first and second connecting means comprises a flange portion and a tubular portion, wherein the flange portion of the first connecting means is fixedly attached to the first filtering means and the flange portion of the second connecting means is fixedly attached to the second filtering means, and wherein the tubular portion of the first connecting means is insertable into the tubular portion of the second connecting means. A securing ring is provided, which is insertable into the tubular portion of the first connecting means and is adapted to exert a radial force on the tubular portion of the first connecting means, pressing the tubular portion of the first connecting means against the tubular portion of the second connecting means. | 08-12-2010 |
Sandrine Miserere, Pantin FR
Patent application number | Description | Published |
---|---|---|
20100104480 | METHOD FOR IMPROVING THE BONDING PROPERTIES OF MICROSTRUCTURED SUBSTRATES, AND DEVICES PREPARED WITH THIS METHOD - A method for treating the surface of a polymerio substrate, including the following steps: providing a first polymeric substrate; contracting at least one part of one face of the first substrate with some liquid solvent system, the liquid solvent system containing at least a first volatile compound and at least a second compound having a low molecular weight and able to swell and/or soften the polymeric material forming the face; letting at least the volatile compound to evaporate from the face of the first substrate and; contracting the so-treated face of first substrate with a third material. | 04-29-2010 |
Sandrine Oberwinkler, Blieskastel DE
Patent application number | Description | Published |
---|---|---|
20100204234 | 17Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors for the Treatment of Hormone-Related Diseases - The invention relates to the use of non-steroidal 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment and prophylaxis of hormone-dependent, particularly estrogen-dependent, diseases. The invention further relates to suitable inhibitors and to a method for the production thereof. | 08-12-2010 |
20110046147 | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-RELATED DISEASES - The invention relates to 17beta-hydroxysteroid dehydrogenase type 1 (17betaHSD1) inhibitors, the preparation thereof and the use thereof for the treatment and prophylaxis of hormone-related, especially estrogen-related or androgen-related, diseases. | 02-24-2011 |
Sandrine Olivier-Mabilais, L'Hay Les Roses FR
Patent application number | Description | Published |
---|---|---|
20100307522 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE AMORPHOUS FILM-FORMING POLYMER AND HAVING A CERTAIN THERMAL PROFILE - The present disclosure relates to a cosmetic composition comprising, in a physiologically acceptable medium, at least one first compound which gives the composition a thermal profile wherein the melting peak has a mid-height width Lf less than or equal to 10° C., and at least one amorphous film-forming polymer capable of forming a water-soluble film, wherein the amorphous film-forming polymer is present in an amount greater than or equal to the amount of the first compound. | 12-09-2010 |
Sandrine Orsoni, Mandelieu FR
Patent application number | Description | Published |
---|---|---|
20080293681 | SPRAYABLE PHARMACEUTICAL COMPOSITIONS COMPRISING A VITAMIN D DERIVATIVE AND AN OILY PHASE - Anhydrous sprayable physically and chemically stable pharmaceutical/dermatological compositions containing a vitamin D derivative as an active pharmaceutical ingredient, particularly calcitriol, and an oily phase are formulated into a physiologically-acceptable medium, and are useful for the treatment of a variety of conditions and afflictions, notably psoriasis. | 11-27-2008 |
20080300229 | SPRAYABLE PHARMACEUTICAL COMPOSITIONS COMPRISING A CORTICOID AND AN OILY PHASE - Anhydrous sprayable pharmaceutical/dermatological compositions containing, as active pharmaceutical agent, a corticoid, preferably clobetasol propionate, and an oily phase, are formulated in a physiologically acceptable medium, and are useful for the treatment of a variety of conditions and afflictions, notably psoriasis. | 12-04-2008 |
20080305060 | AQUEOUS-ALCOHOLIC DEPIGMENTING GELS - Stable, topically applicable cosmetic/pharmaceutical skin depigmenting compositions contain at least one phenolic compound, at least one retinoid and at least one corticoid, and are formulated as aqueous-alcoholic gels in topically applicable, physiologically acceptable media therefor. | 12-11-2008 |
20090069279 | INVERT EMULSIONS CONTAINING DHEA - Stable, recrystallization-resistant invert emulsions, suited, e.g., for preventing/treating the signs of chronological or actinic skin aging and for preventing/treating atrophy of the skin or mucous membranes, comprise a cosmetically/therapeutically effective amount of DHEA and/or chemical and/or biological precursor or derivative thereof, such invert emulsions also comprising a glycolic or hydroglycolic dispersed hydrophilic phase, a lipophilic continuous phase and an emulsifier having an HLB ranging from 2 to 7. | 03-12-2009 |
20100286285 | Pharmaceutical composition comprising oleaginous ointments and vitamin D or its derivatives in the solubilized state - The present invention relates to an anhydrous pharmaceutical composition for use in the treatment of psoriasis and other skin disorders, characterized in that it comprises an oleaginous ointment and, as active ingredient, a compound chosen from vitamin D and its derivatives, said active agent being in a solubilized form in said composition. | 11-11-2010 |
20110152228 | SPRAYABLE PHARMACEUTICAL COMPOSITIONS COMPRISING A CORTICOID AND AN OILY PHASE - Anhydrous sprayable pharamecutical/dermatological compositions containing, as active pharmaceutical agent, a corticoid, preferably clobetasol propionate, and an oily phase, are formulated in a physiologically acceptable medium, and are useful for the treatment of a variety of conditions and afflictions, notably psoriasis. | 06-23-2011 |
20110274724 | DERMATOLOGICAL/COSMETIC GELS COMPRISING AT LEAST ONE RETINOID AND/OR RETINOID SALT AND BENZOYL PEROXIDE - Dermatological/cosmetic gel compositions suited for preventing or treating cell differentiation and/or proliferation and/or keratinization disorders, including preventing or treating common acne, comprise (i) at least one retinoid, (ii) dispersed benzoyl peroxide and (iii) at least one pH-independent gelling agent, formulated into (iv) a physiologically acceptable medium therefor. | 11-10-2011 |
20130046022 | GEL COMPOSITION FOR TREATMENT OF COMMON ACNE COMPRISING A COMBINATION OF BENZOYL PEROXIDE AND ADAPALENE AND/OR ADAPALENE SALT - Dermatological/cosmetic compositions suited for preventing or treating cell differentiation and/or proliferation and/or keratinization disorders, including preventing or treating common acne, comprise, in a physiologically acceptable medium, (i) at least one dispersed retinoid, (ii) dispersed benzoyl peroxide, in free or encapsulated form, and (iii) at least one pH-independent gelling agent, selected from the group consisting of (a) polyacrylamide gelling agents, (b) gelling agents which are acrylic polymers coupled to hydrophobic chains, (c) modified starch gelling agents, and mixture thereof, said composition maintaining good chemical stability of (i) and (ii) without their degradation over time at a temperature of between 4° C. and 40° C. | 02-21-2013 |
Sandrine Orsoni-Segona, Mandelieu FR
Patent application number | Description | Published |
---|---|---|
20110070274 | DERMATOLOGICAL/COSMETIC GELS COMPRISING AT LEAST ONE RETINOID AND BENZOYL PEROXIDE - Dermatological/cosmetic gel compositions suited for preventing or treating cell differentiation and/or proliferation and/or keratinization disorders, including preventing or treating common acne, comprise (i) at least one retinoid, (ii) dispersed benzoyl peroxide and (iii) at least one pH-independent gelling agent, formulated into (iv) a physiologically acceptable medium therefor. | 03-24-2011 |
Sandrine Paroz, Saint-Lambert CA
Patent application number | Description | Published |
---|---|---|
20110125590 | System and method for managing and optimizing advertising campaigns managed on the internet - The system of the present invention is used to optimize the returns of advertising campaigns on the internet. The system allows to create portfolios of keywords and to optimize these portfolios. Moreover, the system allows to classify the keywords in the portfolios according to their past data and to agitate the keywords which held a stagnant position over a pre-set period of time. | 05-26-2011 |
Sandrine Paroz, Saint-Constant CA
Patent application number | Description | Published |
---|---|---|
20120084141 | System and Method to Predict the Performance of Keywords for Advertising Campaigns Managed on the Internet - Historical data from keywords in a pay-per-click internet advertising campaign are used to predict performance of other keywords with the goal of optimizing a keyword portfolio to maximize returns from the advertising campaign. A computing system receives the keyword portfolio for the advertising campaign, and classifies the keywords based on whether or not sufficient historical data exist to generate acceptable predictions about the performance of the keywords in the advertising campaign. Historical data are then used to make performance predictions for keywords having sufficient data. For keywords without sufficient historical data, generic prediction functions are created based on a generic change rate obtained from keywords with sufficient historical data. These generic prediction functions are then used to predict keyword performance in the advertising campaign. Predictions for keywords with and without sufficient historical data are then used to optimize the advertising campaign. | 04-05-2012 |
Sandrine Piguel, Massy FR
Patent application number | Description | Published |
---|---|---|
20090069222 | Compounds Useful as Modulators of the Proteasome Activity - The present invention relates to the use of compounds of the following general formula (I): wherein n | 03-12-2009 |
Sandrine Pinchon, Nointel FR
Patent application number | Description | Published |
---|---|---|
20090068443 | HIGHLY CHEMICAL-RESISTANT GLOVE - The invention concerns an article for protecting the user from risks associated with the handling of chemicals, and comprising: (i) at least one inner layer of a material selected among natural and synthetic latexes; (ii) at least one partly hydrolyzed polyvinyl alcohol (PVA) layer, having an hydrolysis rate ranging between 70 and 95%; (iii) at least one self-crosslinking synthetic latex layer. | 03-12-2009 |
Sandrine Piotelat, Faucigny FR
Patent application number | Description | Published |
---|---|---|
20090198176 | Medication Delivery Device - The medication delivery device is designed to receive a replaceable medication container ( | 08-06-2009 |
20090318878 | Medication Delivery Device - The medication delivery device is designed to receive a replaceable medication container and to determine an adjusted medication dose AD before each delivery of the medication contained in the medication container if the current content of the medication container is not a multiple of a prescribed dose D and is greater than the prescribed dose D. The adjusted medication dose AD is the dose to be delivered instead of the prescribed dose D during said medication delivery. The adjusted medication dose AD is determined by selecting one of a first dose, to that is higher than the prescribed dose D, and of a second dose, that is lower than the prescribed dose D, as a function of a variable B that cumulates the values (AD−D). | 12-24-2009 |
20120007582 | MEDICATION DELIVERY DEVICE - The medication delivery device is designed to receive a replaceable medication container and to determine an adjusted medication dose AD for each medication container received if the amount of medication contained in the medication container is not a multiple of a prescribed dose D. The adjusted medication dose is the dose to be delivered instead of the prescribed dose at each use of the medication delivery device with the medication container received. The adjusted dose is determined by selecting one of a first dose, that is higher than the prescribed dose, and of a second dose, that is lower than the prescribed dose, as a function of a variable B that cumulates the values nAD·(AD−D), where nAD is equal to INT(Cont/AD) and Cont is the amount of medication in the medication container received. | 01-12-2012 |
Sandrine Poteau, Sugar Land, TX US
Patent application number | Description | Published |
---|---|---|
20110284239 | NON-STICK ARTICLES - There is disclosed a non-stick apparatus, comprising a liquid storage or conveyance article comprising a first material; a coating on an internal surface of the article comprising a second material; wherein the second material comprises a critical surface tension value less than 75 mN/m and a hardness value of at least 5 measured on a Moh's scale. | 11-24-2011 |
Sandrine Pouly, Geneve CH
Patent application number | Description | Published |
---|---|---|
20080286227 | Use of Il-17F for the Treatment and/or Prevention of Neurologic Diseases - The invention relates to the use of IL-17F, or of an agonist of IL-17F activity, for treatment or prevention of neurologic diseases. | 11-20-2008 |
Sandrine Pozzolo, Claye Souilly FR
Patent application number | Description | Published |
---|---|---|
20100270495 | LIQUID RESIN COMPOSITION FOR ABRASIVE ARTICLES - The invention relates to a thermally curable liquid resin composition intended for manufacturing abrasives that comprises at least one epoxy resin comprising at least two epoxy groups and at least one reactive diluent, said composition having a viscosity, at 25° C., less than or equal to 7000 mPa.s. | 10-28-2010 |
20100298505 | LIQUID RESIN COMPOSITION FOR ABRASIVE ARTICLES - The invention relates to a liquid resin composition intended for manufacturing abrasives that comprises at least one novolac resin having a glass transition temperature less than or equal to 60° C., at least one reactive diluent and optionally at least one crosslinking agent. | 11-25-2010 |
20130091778 | LIQUID RESIN COMPOSITION FOR ABRASIVE ARTICLES - The invention relates to a thermally curable liquid resin composition intended for manufacturing abrasives that comprises at least one epoxy resin comprising at least two epoxy groups and at least one reactive diluent, said composition having a viscosity, at 25° C., less than or equal to 7000 mPa·s. | 04-18-2013 |
Sandrine Rancien, Voiron FR
Patent application number | Description | Published |
---|---|---|
20120103545 | LASER-MARKABLE SUBSTRATE, AND ASSOCIATED MANUFACTURING METHOD - The present invention relates to a laser-markable substrate, comprising at least one material capable of forming a colored mark under laser irradiation and at least one tamper-proof agent producing an irreversible visible coloration when an attempt is made to chemically erase the mark. | 05-03-2012 |
20150027218 | SECURITY SUBSTRATE, AND METHOD FOR AUTHENTICATION AND FOR REVEALING ATTEMPTS AT FORGERY - A security substrate may include at least one area for authentication and/or for revealing attempts at forgery using solvents. The at least one area may include individualized polymer- or copolymer-based particles comprising at least one visible or detectable marker. The polymer or copolymer may be at least partially soluble in solvents used for forgery. | 01-29-2015 |
Sandrine Rimbert, Antony FR
Patent application number | Description | Published |
---|---|---|
20090142289 | COMPOSITION CONTAINING A HARD WAX AND A PASTY COMPOUND, AND PROCESS FOR THE CARE OR MAKING UP OF THE EYELASHES - Composition containing an aqueous phase, at least 10% by weight of at least one hard wax, relative to the total weight of the composition, and at least one pasty compound. Also described is a composition containing an aqueous phase, at least one hard wax, at least one pasty compound, and possibly at least one oil, the hard wax(es)/(pasty compound(s)+possible oil(s)) weight ratio ranging from 2 to 8. The uses thereof for the care or the making up of keratinous fibres and in particular the eyelashes are also described. | 06-04-2009 |
Sandrine Roblot, Rospez FR
Patent application number | Description | Published |
---|---|---|
20090128250 | POWER LINE TRANSMISSION - A device including an element for receiving an electrical signal comprising a high-frequency data signal component and a low-frequency power supply component. The electrical signal is conveyed in an electrical cable of an electrical installation. The device further includes impedance matching operative in a band of frequencies of the high-frequency signal component, the impedance matching being determined as a function of one or more characteristics of the electrical cable. Such a device can be integrated into a socket outlet or an electrical device or take the form of a socket adaptor. | 05-21-2009 |
Sandrine Saint-Girons, Pully CH
Patent application number | Description | Published |
---|---|---|
20110174325 | Flexible Package for Tobacco Material - A package for tobacco material includes a portion of tobacco material, a wrapper enclosing the portion of tobacco material, a rigid base portion and at least one resealable adhesive label sealing the wrapper around the portion of tobacco material. The wrapper is formed of a flexible sheet material. The package may include an opening strip defined by one or more lines of weakness in the wrapper | 07-21-2011 |
Sandrine Samson-Villeger, Lyon FR
Patent application number | Description | Published |
---|---|---|
20100074877 | COMPOSITION FOR IMPROVING SKIN QUALITY AND A PROCESS FOR PREPARING THE SAME - The present invention relates to a composition including, as active substance, a mixture of at least one polyunsaturated fatty acid, different from polyunsaturated fatty acid derived from milk, polyphenols, milk proteins and lactic bacteria, and the composition having a water content of at least 50% by weight; and wherein the polyunsaturated fatty acid presents an increased bioavailability compared with the one of the polyunsaturated fatty acid alone. | 03-25-2010 |
20100129334 | Use of Lactobacillus casei for Increasing the Protection Provided by the Influenza Vaccine - The invention relates to the use of | 05-27-2010 |
20110104274 | NOVEL COMPOSITION AND USES THEREOF, IN PARTICULAR COSMETIC USES, FOR TREATING SKIN DEHYDRATION - The present invention relates to the use of a combination comprising gamma-linolenic acid and at least one green tea polyphenol, in which the ratio of the gamma-linolenic acid to the green tea polyphenol ranges from approximately 1 to approximately 10, for increasing the in vitro and ex vivo differentiation of keratinocytes. | 05-05-2011 |
Sandrine Silvente-Poirot, L'Union FR
Patent application number | Description | Published |
---|---|---|
20120100124 | METHODS FOR DETERMINING THE ONCOGENIC CONDITION OF CELL, USES THEREOF, AND METHODS FOR TREATING CANCER - The invention relates to methods for detecting the oncogenic condition of cells, including step where the amount of the OCDO compound in said cells is measured, and to the uses thereof. The invention further relates to OCDO inhibitors for use in methods for treating cancer. | 04-26-2012 |
20140221353 | Methods for Determining the Oncogenic Condition of Cell, Uses Thereof, and Methods for Treating Cancer - The invention relates to methods for detecting the oncogenic condition of cells, including step where the amount of the OCDO compound in said cells is measured, and to the uses thereof. The invention further relates to OCDO inhibitors for use in methods for treating cancer. | 08-07-2014 |
Sandrine Talano, St Laurent Du Var FR
Patent application number | Description | Published |
---|---|---|
20110311466 | NOVEL 4-(AZACYCLOALKYL)BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS - 4-(azacycloalkyl)benzene-1,3-diol compounds are described corresponding to general formula (I) below: | 12-22-2011 |
Sandrine Talano, Vence FR
Patent application number | Description | Published |
---|---|---|
20100144814 | NOVEL 4-PHENYLIMIDAZOLE-2-THIONE TYROSINASE INHIBITORS AND PHARMACEUTICAL/COSMETIC APPLICATIONS THEREOF - Novel 4-phenylimidazole-2-thione tyrosinase inhibiting compounds corresponding to the following general formula (I): | 06-10-2010 |
20100292296 | NOVEL LIGANDS THAT MODULATE RAR RECEPTORS - Novel ligand compounds having the general formula (I): | 11-18-2010 |
20120258996 | NOVEL LIGANDS THAT MODULATE RAR RECEPTORS - Novel ligand compounds having the general formula (I): | 10-11-2012 |
20130023516 | 4-(AZACYCLOALKYL)BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS - 4-(azacycloalkyl)benzene-1,3-diol compounds are described corresponding to general formula (I) below: | 01-24-2013 |
20140187532 | 4-(AZACYCLOALKYL)BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS - 4-(azacycloalkyl)benzene-1,3-diol compounds are described corresponding to general formula (I) below: | 07-03-2014 |
20140371197 | 4-(AZACYCLOALKYL)BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS - 4-(Azacycloalkyl)benzene-1,3-diol compounds are described corresponding to general formula (I) below: | 12-18-2014 |
Sandrine Villeger, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20100107962 | STERILISATION INDICATOR - The invention provides a sterilization indicator ( | 05-06-2010 |
20130171688 | STERILISATION INDICATOR - A sterilization indicator having a compound that is of the heating type when put into contact with atoms of oxygen O and/or nitrogen N; and a thermochromic dye, in thermal contact with the compound. | 07-04-2013 |
Sandrine Zameo, Paris FR
Patent application number | Description | Published |
---|---|---|
20100081708 | ANTICOAGULANT COMPOUNDS - The present invention is concerned with anticoagulants (i.e. substances that stop blood from clotting). More specifically, the present invention is concerned with orally available antithrombic oligosaccharides. | 04-01-2010 |